ARCHIVES

Assurances On Methods For Misconduct Reporting Required

This article is from The Cancer Letter archive.

Vol. 15 No. 46 | December 1, 1989

Download PDF Visit The Full Archive

Related Articles

With Fighter Planes Overhead, ODAC Kept Deliberating.

September 21, 2001

Arimidex Continues To Show Improvement Over Tamoxifen

December 27, 2002

NIH News: NTP To test Herbs for Toxicity

August 13, 1999

FDA News: Agency Abandons Plan To Merge Two Offices, Citing Delay Request From Employees’ Union

June 19, 1998

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

NCI, American Cancer Society Re-Evaluating Join Guidelines On Mammography Screening

September 17, 1993